The present study aimed to investigate the occurrence of caffeine residues in the Nile River according to drainage of treated wastewater at Assiut, Egypt, and the effects of physicochemical parameters and zinc on its concentration. Four different sites were selected to perform the study: S, wastewater treatment plant (WWTP) canal (source site); J, a junction site between WWTP canal and the Nile; R, a reference site in the Nile before J site; and A, a site located after J site in the Nile. Water and sediment samples were collected in Summer 2022 and Winter 2023. Caffeine and Zn concentrations and physicochemical parameters were measured in the collected samples. The caffeine concentrations in water samples ranged from 5.73 to 53.85 μg L at S in winter and summer, respectively, while those in sediment ranged from 0.14 mg kg at R in winter to 1.54 mg kg at S in summer. Caffeine and Zn concentrations were higher in summer samples. The Water Quality Index (WQI) of the collected samples recorded the lowest values in winter season at S and J sites. The study found that caffeine and zinc concentrations are positively correlated with water temperature and conductivity, while negatively correlated with pH. The association between caffeine and Zn highlights the environmental impact of heavy metals and pharmaceutical residues, and stresses the need for future research on these interactions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11058622PMC
http://dx.doi.org/10.1007/s11356-024-32918-6DOI Listing

Publication Analysis

Top Keywords

caffeine concentrations
12
treated wastewater
8
nile river
8
physicochemical parameters
8
wwtp canal
8
site nile
8
collected samples
8
caffeine
6
site
6
nile
5

Similar Publications

Threshold determination forms an integral part of sensory and consumer studies applied for product control and development. The authors examined the potential of an impedimetric electronic tongue to discriminate basic tastes and consider limitations pertaining to the sensory evaluation process. Three samples at lower, medium, and higher concentration levels of basic taste compounds were prepared and subjected to consumer studies (n = 60) using the difference from-control (DFC) test.

View Article and Find Full Text PDF

1-Methylxanthine (1-MX) is the major metabolite of caffeine and paraxanthine and might contribute to their activity. 1-MX is an adenosine receptor antagonist and increases the release and survivability of neurotransmitters; however, no study has addressed the potential physiological effects of 1-MX ingestion. The aim of this study was to compare the effect of 1-MX on memory and related biomarkers in rats compared to control.

View Article and Find Full Text PDF

This study examines pharmaceutical residues in the seawater of west Spitsbergen fjords, using indicator compounds that represent different types of medications with various therapeutic uses (sulfamethoxazole, trimethoprim, carbamazepine, diclofenac, and caffeine). Over three years (summer 2018-2021), trimethoprim, carbamazepine, diclofenac, and caffeine were detected in the investigated fjords (Hornsund, Adventfjorden, Grønnfjorden, Isfjorden, and Kongsfjorden), with diclofenac and caffeine being the most common. Sulfamethoxazole was below the limit of detection in all samples.

View Article and Find Full Text PDF

In this research, the photophysical properties of metformin hydrochloride (MF-HCl) were studied using spectroscopic and molecular docking techniques. The interaction between metformin hydrochloride and caffeine is essential for understanding the pharmacokinetics of metformin, particularly in populations with high caffeine consumption. Metformin is a first-line medication for managing type 2 diabetes, while caffeine is a widely consumed dietary stimulant.

View Article and Find Full Text PDF

Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043-02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial.

Lancet Microbe

December 2024

Institute of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, Germany; German Center for Infection Research, Munich Partner Site, Munich, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology, Infection, and Pandemic Research, Munich, Germany; Unit Global Health, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany. Electronic address:

Background: The broad use of bedaquiline and pretomanid as the mainstay of new regimens to combat tuberculosis is a risk due to increasing bedaquiline resistance. We aimed to assess the safety, bactericidal activity, and pharmacokinetics of BTZ-043, a first-in-class DprE1 inhibitor with strong bactericidal activity in murine models.

Methods: This open-label, dose-expansion, randomised, controlled, phase 1b/2a trial was conducted in two specialised tuberculosis sites in Cape Town, South Africa.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!